Floatz logo

RED BLOOD CELLS

Bronchopulmonary Dysplasia (BPD)

Hospital Clinic of BarcelonaCell therapyN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Bronchopulmonary Dysplasia (BPD) cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
National Center for Research Resources (NCRR)
Phase 3B
Solu-Cortef
National Center for Research Resources (NCRR)
Phase 2B
PERFLUTREN
Thunder Bay Regional Health Research Institute
Early Phase 1C
Sonovue
Thunder Bay Regional Health Research Institute
Early Phase 1C
XENON
Thunder Bay Regional Health Research Institute
Early Phase 1C
Helium
Thunder Bay Regional Health Research Institute
Early Phase 1C
Cord Blood Red Blood Cells
Hospital Clinic of Barcelona
N/AD

Same molecule, other indications

RED BLOOD CELLS is also rated in:

beta-thalassemia majorDormant
B
Indicative ·
62 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
CC
Indicative ·
46 / 100
View asset →
retinopathy of prematurityDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →